Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

DIVIS LABORATORIES vs CIPLA - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    DIVIS LABORATORIES CIPLA DIVIS LABORATORIES/
CIPLA
 
P/E (TTM) x 31.6 32.6 97.1% View Chart
P/BV x 8.4 4.0 209.3% View Chart
Dividend Yield % 0.8 0.5 167.3%  

Financials

 DIVIS LABORATORIES   CIPLA
EQUITY SHARE DATA
    DIVIS LABORATORIES
Mar-22
CIPLA
Mar-22
DIVIS LABORATORIES/
CIPLA
5-Yr Chart
Click to enlarge
High Rs5,4251,083 500.9%   
Low Rs3,562806 441.8%   
Sales per share (Unadj.) Rs337.5269.7 125.1%  
Earnings per share (Unadj.) Rs111.531.7 351.5%  
Cash flow per share (Unadj.) Rs123.344.8 275.4%  
Dividends per share (Unadj.) Rs30.005.00 600.0%  
Avg Dividend yield %0.70.5 126.1%  
Book value per share (Unadj.) Rs441.8257.8 171.4%  
Shares outstanding (eoy) m265.47806.81 32.9%   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x13.33.5 380.2%   
Avg P/E ratio x40.329.8 135.3%  
P/CF ratio (eoy) x36.521.1 172.7%  
Price / Book Value ratio x10.23.7 277.5%  
Dividend payout %26.915.8 170.7%   
Avg Mkt Cap Rs m1,192,890762,177 156.5%   
No. of employees `000NANA-   
Total wages/salary Rs m9,46235,299 26.8%   
Avg. sales/employee Rs Th00-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th00-  
INCOME DATA
Net Sales Rs m89,598217,633 41.2%  
Other income Rs m1,1593,217 36.0%   
Total revenues Rs m90,757220,851 41.1%   
Gross profit Rs m38,81143,298 89.6%  
Depreciation Rs m3,11510,520 29.6%   
Interest Rs m201,064 1.9%   
Profit before tax Rs m36,83534,933 105.4%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m7,2319,338 77.4%   
Profit after tax Rs m29,60525,595 115.7%  
Gross profit margin %43.319.9 217.7%  
Effective tax rate %19.626.7 73.4%   
Net profit margin %33.011.8 281.0%  
BALANCE SHEET DATA
Current assets Rs m96,104147,108 65.3%   
Current liabilities Rs m24,54449,129 50.0%   
Net working cap to sales %79.945.0 177.4%  
Current ratio x3.93.0 130.8%  
Inventory Days Days963 13.9%  
Debtors Days Days9876 17,192.8%  
Net fixed assets Rs m50,087119,415 41.9%   
Share capital Rs m5311,614 32.9%   
"Free" reserves Rs m116,751206,364 56.6%   
Net worth Rs m117,282207,977 56.4%   
Long term debt Rs m04,162 0.0%   
Total assets Rs m146,191266,523 54.9%  
Interest coverage x1,842.833.8 5,444.4%   
Debt to equity ratio x00 0.0%  
Sales to assets ratio x0.60.8 75.1%   
Return on assets %20.310.0 202.6%  
Return on equity %25.212.3 205.1%  
Return on capital %31.417.0 185.2%  
Exports to sales %026.2 0.0%   
Imports to sales %19.78.2 241.2%   
Exports (fob) Rs mNA57,094 0.0%   
Imports (cif) Rs m17,67617,803 99.3%   
Fx inflow Rs m78,44560,180 130.4%   
Fx outflow Rs m17,95317,803 100.8%   
Net fx Rs m60,49242,376 142.8%   
CASH FLOW
From Operations Rs m19,11833,259 57.5%  
From Investments Rs m-21,949-18,719 117.3%  
From Financial Activity Rs m-5,324-15,998 33.3%  
Net Cashflow Rs m-8,156-1,323 616.4%  

Share Holding

Indian Promoters % 51.9 13.5 385.0%  
Foreign collaborators % 0.0 20.1 -  
Indian inst/Mut Fund % 36.5 49.0 74.5%  
FIIs % 16.5 27.6 59.8%  
ADR/GDR % 0.0 0.0 -  
Free float % 48.1 66.4 72.4%  
Shareholders   346,905 418,910 82.8%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare DIVIS LABORATORIES With:   SUN PHARMA    DR. REDDYS LAB    LUPIN    ZYDUS LIFESCIENCES    AUROBINDO PHARMA    



Today's Market

Sensex Tanks 652 Points, Nifty Ends Below 17,800; IndusInd Bank & Bajaj Finserv Top Losers(Closing)

After opening the day on a flat note, Indian share markets turned volatile during the afternoon session and fell hard as selling was seen in banking and auto stocks.